A citation-based method for searching scientific literature

Tsuneyuki Oda, Akimasa Sekine, Terufumi Kato, Tomohisa Baba, Koji Okudela, Takashi Ogura. Respir Investig 2015
Times Cited: 8







List of co-cited articles
27 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Palliative chemotherapy for pulmonary pleomorphic carcinoma.
Hyun-Mi Bae, Hye Sook Min, Se-Hoon Lee, Dong-Wan Kim, Doo Hyun Chung, Jong-Seok Lee, Young Whan Kim, Dae Seog Heo. Lung Cancer 2007
109
75

The Successful Treatment of Pulmonary Pleomorphic Carcinoma with Pembrolizumab: A Case Report.
Yoko Matsumoto, Tamaki Miura, Hajime Horiuchi, Kazuhiro Usui. Case Rep Oncol 2017
26
75


Successful treatment of two consecutive cases of pulmonary pleomorphic carcinoma with platinum chemotherapy.
Daisuke Kato, Yuichi Chihara, Tomoyuki Shirase, Tamaki Takahashi, Ken-Ichi Takahashi, Naoki Sakai. Oncol Lett 2015
7
57

Retrospective analysis of the efficacy of chemotherapy and molecular targeted therapy for advanced pulmonary pleomorphic carcinoma.
Yosuke Tamura, Yutaka Fujiwara, Noboru Yamamoto, Hiroshi Nokihara, Hidehito Horinouchi, Shintaro Kanda, Yasushi Goto, Emi Kubo, Shinsuke Kitahara, Kenjiro Tsuruoka,[...]. BMC Res Notes 2015
23
50

Pulmonary pleomorphic carcinoma: a clinicopathological study including EGFR mutation analysis.
Kyoichi Kaira, Yoshiki Horie, Eriko Ayabe, Haruyasu Murakami, Toshiaki Takahashi, Asuka Tsuya, Yukiko Nakamura, Tateaki Naito, Masahiro Endo, Haruhiko Kondo,[...]. J Thorac Oncol 2010
73
50

Programmed death-1 ligand 1 and 2 are highly expressed in pleomorphic carcinomas of the lung: Comparison of sarcomatous and carcinomatous areas.
Sehui Kim, Moon-Young Kim, Jaemoon Koh, Heounjeong Go, Dong Soo Lee, Yoon Kyung Jeon, Doo Hyun Chung. Eur J Cancer 2015
121
50

Pleomorphic (spindle/giant cell) carcinoma of the lung. A clinicopathologic correlation of 78 cases.
N F Fishback, W D Travis, C A Moran, D G Guinee, W F McCarthy, M N Koss. Cancer 1994
211
50

Case series of pleomorphic carcinomas of the lung treated with nivolumab.
Masaki Kanazu, Takeshi Uenami, Yukihiro Yano, Saeko Nakatsubo, Yuki Hosono, Mikako Ishijima, Yuki Akazawa, Toshihiko Yamaguchi, Koji Urasaki, Masahide Mori,[...]. Thorac Cancer 2017
31
50

Pleomorphic carcinoma of the lung: clinicopathologic characteristics of 70 cases.
Takahiro Mochizuki, Genichiro Ishii, Kanji Nagai, Junji Yoshida, Mitsuyo Nishimura, Tetsuya Mizuno, Tomoyuki Yokose, Kazuya Suzuki, Atsushi Ochiai. Am J Surg Pathol 2008
133
50

The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification.
William D Travis, Elisabeth Brambilla, Andrew G Nicholson, Yasushi Yatabe, John H M Austin, Mary Beth Beasley, Lucian R Chirieac, Sanja Dacic, Edwina Duhig, Douglas B Flieder,[...]. J Thorac Oncol 2015
50

Clinical characteristics of pleomorphic carcinoma of the lung.
Kenichiro Ito, Satoshi Oizumi, Shinichi Fukumoto, Masao Harada, Takashi Ishida, Yuka Fujita, Toshiyuki Harada, Tetsuya Kojima, Hiroshi Yokouchi, Masaharu Nishimura. Lung Cancer 2010
80
37

Pleomorphic carcinoma of the lung: a surgical outcome.
Tsuyoshi Yuki, Toshiko Sakuma, Chiho Ohbayashi, Masahiro Yoshimura, Noriaki Tsubota, Yutaka Okita, Morihito Okada. J Thorac Cardiovasc Surg 2007
82
37

Pulmonary pleomorphic carcinoma with few PD-1-positive immune cells and regulatory T cells that showed a complete response to nivolumab.
Kazuaki Okamura, Yuichi Fukuda, Hiroshi Soda, Daiki Ogawara, Keisuke Iwasaki, Shinichiro Fuchi, Takayuki Suyama, Masataka Yoshida, Tatsuhiko Harada, Minoru Fukuda,[...]. Thorac Cancer 2018
13
37

The role of palliative chemotherapy for advanced pulmonary pleomorphic carcinoma.
Jung Yong Hong, Moon Ki Choi, Ji Eun Uhm, Min Jae Park, Jeeyun Lee, Yeon Hee Park, Jin Seok Ahn, Keunchil Park, Joung Ho Han, Myung Ju Ahn. Med Oncol 2009
44
37

"Pseudoprogression" of Pulmonary Pleomorphic Carcinoma during Nivolumab Therapy.
Kentaro Ito, Osamu Hataji, Koji Katsuta, Tetsu Kobayashi, Esteban C Gabazza, Yasushi Yatabe, Osamu Taguchi, Nobuyuki Yamamoto. J Thorac Oncol 2016
24
37

Marked response to pembrolizumab in a patient with pulmonary pleomorphic carcinoma highly positive for PD-L1.
Yuki Ikematsu, Yasuto Yoneshima, Kayo Ijichi, Kentaro Tanaka, Taishi Harada, Yoshinao Oda, Yoichi Nakanishi, Isamu Okamoto. Lung Cancer 2017
19
37

Pulmonary carcinomas with pleomorphic, sarcomatoid, or sarcomatous elements: a clinicopathologic and immunohistochemical study of 75 cases.
Giulio Rossi, Alberto Cavazza, Nathalie Sturm, Mario Migaldi, Nicola Facciolongo, Lucia Longo, Antonio Maiorana, Elisabeth Brambilla. Am J Surg Pathol 2003
217
37

Pulmonary pleomorphic carcinoma with pembrolizumab monotherapy.
Hao-Chun Chang, Chia-Lin Hsu, Yih-Leong Chang, Chong-Jen Yu. Respirol Case Rep 2020
3
100

Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer.
Hossein Borghaei, Luis Paz-Ares, Leora Horn, David R Spigel, Martin Steins, Neal E Ready, Laura Q Chow, Everett E Vokes, Enriqueta Felip, Esther Holgado,[...]. N Engl J Med 2015
25

Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer.
Martin Reck, Delvys Rodríguez-Abreu, Andrew G Robinson, Rina Hui, Tibor Csőszi, Andrea Fülöp, Maya Gottfried, Nir Peled, Ali Tafreshi, Sinead Cuffe,[...]. N Engl J Med 2016
25

Definitive Chemoradiotherapy for Advanced Pulmonary Sarcomatoid Carcinoma.
Kazuya Takeda, Haruo Matsushita, Masaki Kubozono, Takaya Tanabe, Yojiro Ishikawa, Takaya Yamamoto, Maiko Kozumi, Noriyoshi Takahashi, Yu Katagiri, Shun Tasaka,[...]. Intern Med 2016
2
100

Personal experience in surgical management of pulmonary pleomorphic carcinoma.
Federico Raveglia, Maurizio Mezzetti, Tiziana Panigalli, Simone Furia, Luigi Giuliani, Serena Conforti, Stefano Meda. Ann Thorac Surg 2004
82
25

Single pembrolizumab treatment causing profound durable response in a patient with pulmonary pleomorphic carcinoma.
Hirokazu Tokuyasu, Soichiro Ishikawa, Hiromitsu Sakai, Tomoyuki Ikeuchi, Hiroshi Miura. Respir Med Case Rep 2019
7
28

A Case of Pulmonary Pleomorphic Carcinoma With Renal Metastasis.
Yasuomi Shimizu, Taro Iguchi, Yujiro Nitta, Yuichi Machida, Katsuyuki Kuratsukuri, Hidenori Kawashima, Tatsuya Nakatani. Urol Case Rep 2014
4
50

Long-term survival in a case of pleomorphic carcinoma with a brain metastasis.
Keiji Yamanashi, Satoshi Marumo, Koki Miura, Masahiro Kawashima. Case Rep Oncol 2014
12
25

Outstanding clinical efficacy of PD-1/PD-L1 inhibitors for pulmonary pleomorphic carcinoma.
Jiyun Lee, Yoon La Choi, Hyun Ae Jung, Se-Hoon Lee, Jin Seok Ahn, Myung-Ju Ahn, Keunchil Park, Jong-Mu Sun. Eur J Cancer 2020
18
25

Nivolumab versus docetaxel in previously treated advanced non-small-cell lung cancer (CheckMate 017 and CheckMate 057): 3-year update and outcomes in patients with liver metastases.
E E Vokes, N Ready, E Felip, L Horn, M A Burgio, S J Antonia, O Arén Frontera, S Gettinger, E Holgado, D Spigel,[...]. Ann Oncol 2018
292
12

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer.
Julie Brahmer, Karen L Reckamp, Paul Baas, Lucio Crinò, Wilfried E E Eberhardt, Elena Poddubskaya, Scott Antonia, Adam Pluzanski, Everett E Vokes, Esther Holgado,[...]. N Engl J Med 2015
12

Sarcomatoid lung carcinomas show high levels of programmed death ligand-1 (PD-L1).
Vamsidhar Velcheti, David L Rimm, Kurt A Schalper. J Thorac Oncol 2013
115
12

Global cancer statistics, 2002.
D Max Parkin, Freddie Bray, J Ferlay, Paola Pisani. CA Cancer J Clin 2005
12

Tumor angiogenesis in 75 cases of pleomorphic carcinoma of the lung.
Yukari Tsubata, Akihisa Sutani, Tamio Okimoto, Motoki Matsuura, Isao Murakami, Ryousuke Usuda, Tsuneo Okumichi, Sei-Ichi Kakegawa, Kenichi Togashi, Shinji Kosaka,[...]. Anticancer Res 2012
9
12

Clinical advances in the development of novel VEGFR2 inhibitors.
Caterina Fontanella, Elena Ongaro, Silvia Bolzonello, Michela Guardascione, Gianpiero Fasola, Giuseppe Aprile. Ann Transl Med 2014
153
12

PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity.
Sydney R Gordon, Roy L Maute, Ben W Dulken, Gregor Hutter, Benson M George, Melissa N McCracken, Rohit Gupta, Jonathan M Tsai, Rahul Sinha, Daniel Corey,[...]. Nature 2017
12

Reductions in myeloid-derived suppressor cells and lung metastases using AZD4547 treatment of a metastatic murine breast tumor model.
Li Liu, Ting Hong Ye, Yuan Ping Han, Hang Song, Yong Kui Zhang, Yong Xia, Ning Yu Wang, Ying Xiong, Xue Jiao Song, Yong Xia Zhu,[...]. Cell Physiol Biochem 2014
34
12

Upregulation of EGFR signaling is correlated with tumor stroma remodeling and tumor recurrence in FGFR1-driven breast cancer.
Xue B Holdman, Thomas Welte, Kimal Rajapakshe, Adam Pond, Cristian Coarfa, Qianxing Mo, Shixia Huang, Susan G Hilsenbeck, Dean P Edwards, Xiang Zhang,[...]. Breast Cancer Res 2015
48
12

Review article: pulmonary sarcomatoid carcinomas: a practical overview.
Giuseppe Pelosi, Angelica Sonzogni, Tommaso De Pas, Domenico Galetta, Giulia Veronesi, Lorenzo Spaggiari, Michela Manzotti, Caterina Fumagalli, Enrica Bresaola, Oscar Nappi,[...]. Int J Surg Pathol 2010
106
12

Pembrolizumab and platinum-based chemotherapy as first-line therapy for advanced non-small-cell lung cancer: Phase 1 cohorts from the KEYNOTE-021 study.
Shirish M Gadgeel, James P Stevenson, Corey J Langer, Leena Gandhi, Hossein Borghaei, Amita Patnaik, Liza C Villaruz, Matthew Gubens, Ralph Hauke, James Chih-Hsin Yang,[...]. Lung Cancer 2018
52
12

Prognostic Significance of Tumor Immunity in Surgically Resected Pulmonary Pleomorphic Carcinoma.
Kyoichi Kaira, Kimihiro Shimizu, Hideki Endoh, Kazuyoshi Imaizumi, Mitsuhiro Kamiyoshihara, Masayuki Sugano, Osamu Kawashima, Shigefumi Tanaka, Atsushi Fujita, Hisao Imai,[...]. Anticancer Res 2020
2
50

Clinicopathological investigation of pulmonary pleomorphic carcinoma.
Satoshi Yamamoto, Daisuke Hamatake, Takao Ueno, Takao Higuchi, Masahumi Hiratsuka, Takeshi Shiraishi, Akinori Iwasaki, Takayuki Shirakusa. Eur J Cardiothorac Surg 2007
26
12

Concurrent combination of irradiation and immune checkpoint inhibitor for recurrent pleomorphic carcinoma of the lung.
Ken Kodama, Tomohiro Maniwa, Yukio Kimura, Yuriko Yagi, Yoko Yamamoto, Toshika Ohkawa, Masashi Takeda, Hiroki Kishima, Genju Koh, Takamasa Toyofuku. Int Cancer Conf J 2017
7
14

Long-term survival in two cases of resected gastric metastasis of pulmonary pleomorphic carcinoma.
Keiju Aokage, Junji Yoshida, Genichiro Ishii, Shinichiro Takahashi, Masanori Sugito, Mitsuyo Nishimura, Atsushi Ochiai, Kanji Nagai. J Thorac Oncol 2008
21
12

An unusual case of duodenal metastasis of pulmonary pleomorphic carcinoma.
Müge Ustaoğlu, Gülgün Koçak, Çiğdem Siviloğlu, Ercüment Cengiz. Turk J Gastroenterol 2018
2
50

Pleomorphic carcinoma of the lung: a report of six cases.
Adnan Yilmaz, Ebru Sulu, Sibel Arinç, Cüneyt Saltürk, Erdal Okur, Ferda Aksoy, Semih Halezeroğlu. Tuberk Toraks 2007
2
50

Pulmonary Sarcomatoid Carcinoma: An Analysis of the National Cancer Data Base.
Conor E Steuer, Madhusmita Behera, Yuan Liu, Chao Fu, Theresa W Gillespie, Nabil F Saba, Dong M Shin, Rathi N Pillai, Suchita Pakkala, Taofeek K Owonikoko,[...]. Clin Lung Cancer 2017
41
12

An early event of EGFR mutation in pleomorphic carcinoma of the lung.
Miyako Saitoh, Mafumi Niijima, Yuichi Takiguchi, Kenzo Hiroshima, Yoshihiko Fujita, Kazuto Nishio, Koichiro Tatsumi. Int J Clin Oncol 2011
7
14

Intussusception caused by intestinal metastasis from lung pleomorphic carcinoma.
Mong-Wei Lin, Chen-Tu Wu, Yih-Leong Chang. Ann Thorac Cardiovasc Surg 2014
5
20

Gastric and pancreatic metastases from pleomorphic lung carcinoma.
A M Ioncica, M Atiq, J H Lee, A Saftoiu, M S Bhutani. Endoscopy 2011
2
50

Role of HIF-1 in Cancer Progression: Novel Insights. A Review.
Aldo Pezzuto, Elisabetta Carico. Curr Mol Med 2018
156
12

Coronary Embolization Caused by Pleomorphic Lung Carcinoma.
Tadashi Murai, Taishi Yonetsu, Mitsuaki Isobe, Tsunekazu Kakuta. Intern Med 2016
3
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.